High Dose Involved Field Radiation Therapy as Salvage for Loco-Regional Recurrence of Non-Small Cell Lung Cancer-Reference-Cited by-同舟云学术

High Dose Involved Field Radiation Therapy as Salvage for Loco-Regional Recurrence of Non-Small Cell Lung Cancer

Published:2012 Issue:6 Volume:53 Page:1120
ISSN:0513-5796
Container-title:Yonsei Medical Journal
language:en
Short-container-title:Yonsei Med J

Author:

Bae Sun Hyun¹,Ahn Yong Chan¹,Nam Heerim²,Park Hee Chul¹,Pyo Hong Ryull¹,Shim Young Mog³,Kim Jhingook³,Kim Kwhanmien³,Ahn Jin Seok⁴,Ahn Myung-Ju⁴,Park Keunchil⁴

Affiliation:

1. Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

2. Department of Radiation Oncology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.

3. Department of Thoracic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

4. Department of Medicine (Division of Hematooncology), Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Publisher

Yonsei University College of Medicine

Subject

General Medicine

Link

https://synapse.koreamed.org/pdf/10.3349/ymj.2012.53.6.1120

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment patterns and survival of patients with locoregional recurrence in early-stage NSCLC: a literature review of real-world evidence;Medical Oncology;2022-10-29

2. Radiation Therapy for Intrathoracic Recurrence of Lung Cancer;Medical Radiology;2022

3. Salvage radiation therapy for postoperative locoregionally recurrent non-small cell lung cancer: a single-center experience;Radiation Oncology Journal;2021-09-30

4. Hypo-fractionated radiotherapy with concurrent chemotherapy for locoregional recurrence of non-small cell lung cancer after complete resection: A prospective, single-arm, phase II study (GASTO-1017);Lung Cancer;2021-06

5. Propensity score adjusted analysis of patients with isolated locoregional recurrence versus de novo locally advanced NSCLC treated with definitive therapy;Lung Cancer;2020-07